01 January 1999
QT dispersion in type 1 diabetic patients with cardiovascular autonomic neuropathy
Krzysztof Wanic, Wojciech Dynowski, Elżbieta Kozek, Danuta Galicka-Latała, Jacek SieradzkiMed Sci Monit 1999; 5(1): CR40-46 :: ID: 505208
Abstract
Increased QT dispersion is believed to be a direct cause of complex ventricular arrhythmias in patients with ischemic heart disease, those receiving antiarrhythmic agents and in patients with cardiovascular autonomic disorders. Diabetic patients with autonomic neuropathy have an increased risk for sudden death due to ventricular arrhythmias. The purpose of this study was to evaluate QT and QTc dispersion and to analyze the effect of cardiovascular autonomic neuropathy on QT and QTc dispersion in patients with type 1 diabetes mellitus. Cardiovascular autonomic neuropathy was assessed by means of a ProSciCard using Ewing's tests. The QT interval was measured manually from three cycles in each of the 12 electrocardiographic leads. The study group comprised 44 patients (23 men, 21 women), including 21 patients with cardiovascular autonomic neuropathy (14 men, 7 women) and 23 patients without cardiovascular autonomic neuropathy (14 women, 9 men). QT dispersion was defined as the difference between the maximum and minimum QT in all leads. The mean QT dispersion in patients with cardiovascular autonomic neuropathy was significantly higher than in patients without autonomic neuropathy (0.0511±0.0159 s; 0.0319±0.0104 s; p<0.001). QTc dispersion was also significantly higher in patients with than without cardiovascular autonomic neuropathy (0.0620±0.0219 s1/2; 0.0501±0.0134 s1/2; p<0.05). Similar correlations were also found following adjustment of the number of leads in which the QT interval was measured: QT dispersion - 0.0153±0.0047 s vs 0.0096±0.0030 s (p<0.001);
QTc dispersion - 0.0184±0.0064 s1/2 vs 0.0150±0.0040 s1/2 (p<0.05). These findings indicate that in patients with cardiovascular autonomic neuropathy, QT and QTc dispersion are increased, which may place them at a higher risk for the development of ventricular arrhythmias.
Keywords: Electrocardiography, type 1 diabetes mellitus, cardiovascular autonomic neuropathy, QT dispersion
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952